News

This marks the second FDA-cleared ECG-AI device in Tempus’ cardiovascular product suite, following its previously cleared Tempus ECG-AF solution. The new software analyzes resting, non-ambulatory ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...
Detectives in Olomouc have used AI to create a probable image of the murderer of a video-rental employee in 2005. From the original facial composite, they have created a probable image of the ...
Investor's Business Daily on MSN23h
Tempus AI Earns Relative Strength Rating Upgrade
Tempus AITEM reached an important technical milestone, with its Relative Strength (RS) Rating moving into the 90-plus ...
GeneDx leverages a vast rare disease database and advanced genomic testing, offering superior insights. Read why I am bullish about WGS stock.
Tempus AI Inc. (NASDAQ:TEM) is one of the best young stocks to buy and hold for 5 years. On July 8, Tempus AI announced the ...
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Tempus AI, Inc. (“Tempus” or the “Company”) (NASDAQ: TEM) investors of ...
Last week, readers were most interested in a story about an extended collaboration between Personalis and Tempus to include colorectal cancer.
ARKK surged in 2Q25 on AI and crypto bets like Circle and Tempus, with strong returns despite outflows and high sector risk.
The global AI infrastructure market is projected to grow at a CAGR of 29.1%, reaching $356.14 billion by 2032 from $36.59 billion in 2023, according to Fortune Business Insights.
Key Takeaways Tempus AI stock shows 15–32% upside potential based on analyst forecasts.The company leads in using artificial ...
Actor Dean Cain played Superman for four seasons in the 90's ABC superhero TV series, Lois & Clark: The New Adventures of ...